FASN and hepatocellular carcinoma: The inhibition of FASN and ACC has shown promising therapeutic effects in reducing HCC cell growth and sensitizing tumors to chemotherapy, highlighting the potential of targeting fatty acid metabolism in the treatment of HCC [82].